Piper Jaffray Reports Solid FQ3 Results For Cyberonics

In a report published by Piper Jaffray, Cyberonics CYBX saw solid FQ3 results.

 

Piper Jaffray said that CYBX reported FQ3 (January) results slightly ahead of expectation; Q4 guidance was essentially inline. “US revenues were up an impressive 24% including 13% new patient growth. OUS (15% of overall revenues) struggled as Europe's austerity reduced new implants and Japan's cautiousness is delaying what we believe will be an inevitable upward inflection point. We reiterate our OW rating and $38 target.”

 

Cyberonics closed yesterday at $32.67.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorAnalyst RatingscyberonicsHealth CareHealth Care EquipmentPiper Jaffray
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!